Gene · 4610
Papers2,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification. | Cancers (Basel) | 2023 | 37046804 | PubTator, text mining | PubMed |
| MYC activation impairs cell-intrinsic IFNγ signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancer. | Cell Rep Med | 2023 | 37044092 | PubTator, text mining | PubMed |
| The functional and clinical roles of liquid biopsy in patient-derived models. | J Hematol Oncol | 2023 | 37031172 | PubTator, text mining | PubMed |
| Chenodeoxycholic acid rescues axonal degeneration in induced pluripotent stem cell-derived neurons from spastic paraplegia type 5 and cerebrotendinous xanthomatosis patients. | Orphanet J Rare Dis | 2023 | 37024986 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Astrocytes mediate cell non-autonomous correction of aberrant firing in human FXS neurons. | Cell Rep | 2023 | 37018073 | PubTator, text mining | PubMed |
| A human induced pluripotent stem cell model from a patient with hereditary cerebral small vessel disease carrying a heterozygous R302Q mutation in HTRA1. | Inflamm Regen | 2023 | 37009886 | PubTator, text mining | PubMed |
| GSK2801 Reverses Paclitaxel Resistance in Anaplastic Thyroid Cancer Cell Lines through MYCN Downregulation. | Int J Mol Sci | 2023 | 36983070 | PubTator, text mining | PubMed |
| G-Quadruplexes in c-MYC Promoter as Targets for Cancer Therapy. | Biomedicines | 2023 | 36979947 | PubTator, text mining | PubMed |
| 2,5-Hexanedione Affects Ovarian Granulosa Cells in Swine by Regulating the CDKN1A Gene: A Transcriptome Analysis. | Vet Sci | 2023 | 36977240 | PubTator, text mining | PubMed |
| Strategies to target the cancer driver MYC in tumor cells. | Front Oncol | 2023 | 36969025 | PubTator, text mining | PubMed |
| The effects of MYC on tumor immunity and immunotherapy. | Cell Death Discov | 2023 | 36966168 | PubTator, text mining | PubMed |
| Oleic acid stimulates cell proliferation and BRD4-L-MYC-dependent glucose transporter transcription through PPARα activation in ovarian cancer cells. | Biochem Biophys Res Commun | 2023 | 36965420 | PubTator, text mining | PubMed |
| Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer. | Front Oncol | 2023 | 36959802 | PubTator, text mining | PubMed |
| Derivation of Sendai-Virus-Reprogrammed Human iPSCs-Neuronal Precursors: In Vitro and In Vivo Post-grafting Safety Characterization. | Cell Transplant | 2023 | 36959733 | PubTator, text mining | PubMed |
| Centipeda minima active components and mechanisms in lung cancer. | BMC Complement Med Ther | 2023 | 36959600 | PubTator, text mining | PubMed |
| Differentiation of patient-specific void urine-derived human induced pluripotent stem cells to fibroblasts and skeletal muscle myocytes. | Sci Rep | 2023 | 36959367 | PubTator, text mining | PubMed |
| Generation of human induced pluripotent stem cell line (BCRTi006-A) from a patient with focal segmental glomerulosclerosis disease. | Stem Cell Res | 2023 | 36958215 | PubTator, text mining | PubMed |
| Platycodin-D exerts its anti-cancer effect by promoting c-Myc protein ubiquitination and degradation in gastric cancer. | Front Pharmacol | 2023 | 36950011 | PubTator, text mining | PubMed |
| Research progress on non-protein-targeted drugs for cancer therapy. | J Exp Clin Cancer Res | 2023 | 36918935 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4610/papers?page=15